Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 5/20 | 0.52 |
| ▸ | GSK3B | P49841 | 4/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13289235 | 0.93 | CDK2 (0.45) | CDK2GSK3BHDAC3HDAC1NAMPT | |
| SCHEMBL14613372 | 0.91 | HDAC1 (0.41) | CDK2GSK3BHDAC3HDAC1NAAA | |
| SCHEMBL13288952 | 0.90 | CDK2 (0.44) | CDK2GSK3BHDAC3HDAC1NAMPT | |
| SCHEMBL13288811 | 0.90 | CDK2 (0.44) | CDK2GSK3BNAMPT | |
| SCHEMBL13289231 | 0.90 | DRD2 (0.46) | CDK2GSK3BHDAC3HDAC1 | |
| SCHEMBL13120201 | 0.89 | CDK2 (0.66) | CDK2GSK3B | |
| SCHEMBL13289182 | 0.89 | CDK2 (0.46) | CDK2GSK3BHDAC1BRD4 | |
| SCHEMBL13288809 | 0.88 | CDK2 (0.43) | CDK2GSK3BHDAC3HDAC1NAMPT | |
| SCHEMBL13289170 | 0.87 | KMT2A (0.45) | CDK2GSK3BHDAC3HDAC1NAMPT | |
| SCHEMBL14545261 | 0.87 | CDK2 (0.53) | CDK2GSK3BCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194058-A1 | Pyrazolopyrimidines suitable for the treatment of cancer diseases | SCHERING CORPORATION (US) | 2010-06-09 | — | — | EP | disclosed |